Clinical Trials

73 studies in Neurology

  1. Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
    1. Minnesota
  2. Natural History and Biospecimen Repository for Dystonia; Comprehensive Rating Tools for Cervical Dystonia; Validity & Reliability of Diagnostic Methods & Measures of Spasmodic Dysphonia
    1. Arizona
  3. Ultrasound-guided Greater Occipital Nerve Injection at Novel Proximal Location: A Clinical Series
    1. Minnesota
  4. Implantable Neurostimulator for the Treatment of Parkinson s Disease
    1. Florida,
    2. Minnesota
  5. PiB PET Scanning in Speech and Language Based Dementias
    1. Minnesota
  6. An Open Label, Multicenter Study, Evaluating the Safety and Efficacy of 18F-AV-133 PET Imaging to Identify Subjects With Dopaminergic Degeneration Among Subjects Presenting to a Movement Disorders Specialty Clinic With an Uncertain Diagnosis
    1. Arizona
  7. A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children With Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial
    1. Minnesota
  8. Temozolomide With Irinotecan Versus Temozolomide, Irinotecan Plus Bevacizumab (NSC# 704865) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, a COG Randomized Phase II Screening Trial
    1. Minnesota
  9. Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
    1. Minnesota
  10. An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (FAP)
    1. Minnesota
  1. Prev
  2. 3
  3. 4
  4. 5
  5. 6
  6. 7
  7. Next